Collectively, data obtained from both mouse lung tumors and human ccRCC revealed a conserved regulatory mechanism of ETV1 transcription upon SETD2 loss through increased chromatin accessibility and intronic enhancer activity. Here, SETD2 is linked to nonpapillary renal cell carcinoma.